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Abstract 
The genetic correlates of extreme impulsive violence are poorly understood, and there have 
been no studies that have systematically characterized a large group of affected individuals 
both clinically and genetically. We performed a genome-wide rare copy number variant 
(CNV) analysis in 281 males from 4 Czech prisons who met strict clinical criteria for extreme 
impulsive violence. Inclusion criteria included age > 18 years, an ICD 10 diagnosis of Dissocial 
Personality Disorder, and the absence of an organic brain disorder. Participants underwent a 
structured psychiatric assessment to diagnose extreme impulsive violence and then 
provided a blood sample for genetic analysis. DNA was genotyped and CNVs were identified 
using Illumina HumanOmni2.5 SNP array platform. Comparing with 15,500 external 
population controls we identified 828 rare CNVs (frequency ≤ 0.1% among control samples) 
in 264 participants. The CNVs impacted 754 genes, with 124 genes impacted more than 
once (2-25-times). Many of these genes are associated with autosomal dominant or X-linked 
disorders affecting adult behaviour, cognition, learning, intelligence, specifically expressed 
in the brain, and relevant to synapses, neurodevelopment, neurodegeneration, obesity and 
neuropsychiatric phenotypes. Specifically we identified 31 CNVs of clinical relevance in 31 
individuals, 59 likely clinically relevant CNVs in 49 individuals, and 17 recurrent CNVs in 65 
individuals. Thus, 123 of 281 (44%) individuals had one to several rare CNVs that were likely 
relevant to impulsive violence. Extreme impulsive violence is genetically heterogeneous and 
genomic analysis is likely required to identify, further research and specifically treat the 
causes in affected individuals. 
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Introduction 
Violent behavior is a poorly understood evolutionary, biological and sociological phenomena 
(Ferguson and Beaver, 2009). It is a complex trait resulting from multiple genetic and 
environmental factors, and their interactions. Despite the growing impact of violent 
behavior on both the individual and society, there is a paucity of research in this area 
(Siever, 2008; Bevilacqua and Goldman, 2013; Rosell and Siever, 2015); partly because 
research in violent behavior raises serious ethical and legal concerns (Berryessa et al., 2013; 
Pieri and Levitt, 2008; Forzano et al., 2010; Editorial, 2013; Berryessa and Cho, 2013). In 
addition, most research has focused on the attribution of specific psychiatric disorders to 
individuals with violent behavior (Heeramun et al., 2017), rather than pursuing a basic 
understanding of the underlying pathophysiology. 
Research in this area is critical in order to better understand the pathophysiology of these 
disorders, classify them, and provide treatment to affected individuals. Over the last few 
decades developments in cognitive neuroscience and behavioral genetics have provided 
new insights into the nature of violent and criminal behavior by identifying genetic, gender-
dependent, physiological, biochemical and neural correlates of impulsivity, violence, and 
related personality disorders (Volavka, 2002; Craig, 2007; Vevera et al., 2009; Bevilacqua 
and Goldman, 2013). 
Twin and family studies have shown that violence, particularly irritable/impulsive violence, 
has substantial heritability, ranging from 44%–72% (Yeh et al., 2010; Rhee and Waldman, 
2002; Seroczynski et al., 1999), and these strong heritability estimates have stimulated 
genetic investigations (Asherson and Cormand, 2016).  
Linkage studies led to the identification of a causal mutation in the gene encoding X-linked 
monoamine oxidase A (MAOA) (Brunner et al., 1993a; Brunner et al., 1993b), with 
confirmation in other families (Piton et al., 2014). Experimental validation of MAOA function 
on behavioral patterns was found in animal models (Cases et al., 1995) as well as in 
association studies in humans (Caspi et al., 2002; Kim-Cohen et al., 2006); for review see 
(Godar et al., 2016; Fernandez-Castillo and Cormand, 2016). 
Candidate gene-based research focusing on the determination of a relationship between 
aggressive behavior and sex-determining and sex-specific genes and common allelic variants 
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in genes involved in neurotransmission, hormone regulation, drug metabolism, 
neurodevelopment, neuroadaptation and regulation of hypothalamic-pituitary-
adrenocortical axis has been mostly inconclusive (Craig and Halton, 2009; Bevilacqua and 
Goldman, 2013; Fernandez-Castillo and Cormand, 2016). Several genome–wide association 
studies on aggressive traits have failed to consistently identify genes associated with violent 
behavior (Fernandez-Castillo and Cormand, 2016). 
Targeted resequencing and a search for rare variants in 14 candidate genes involved in the 
dopamine and serotonin pathways in a cohort of 228 extremely violent Finnish prisoners 
revealed a premature stop codon variant of serotonin receptor 2B (HTR2B). This variant was 
significantly over-represented in cases compared to the control Finnish population (7.5% vs 
1%; odds ratio 3.1; 95%CI 1.3-7.7; p = 0.01). The variant co-segregated with impulsivity in 
multiple families and the phenotype was recapitulated in Htr2b−/− mice (Bevilacqua et al., 
2010). 
Aggression and impulsivity have also been reported in several individuals with large genomic 
rearrangements (copy number variations, CNVs) in chromosomal regions 1q21.1.(Brunetti-
Pierri et al., 2008; Vu et al., 2011), 15q13.3 (Shinawi et al., 2009; Miller et al., 2009; van Bon 
et al., 2009; Vu et al., 2011) and 16p13.11 (Hannes et al., 2009; Ullmann et al., 2007) and 
16q22.2-q23.1 (Vu et al., 2011). These regions contain genes that affect neurobiological 
pathways, suggesting that haploinsufficiency of genes acting in these pathways may 
predispose to aggressive and impulsive behavior (Vu et al., 2011; Brevik et al., 2016), as well 
as to other neuropsychiatric disorders (Malhotra and Sebat, 2012; Cook and Scherer, 2008).  
Aggression and impulsivity may also be linked to the effect of de novo rare genetic variants . 
This theory is supported by a study showing that children born to men older than 60 were 
more likely to be convicted of violent crimes than children born to men aged 40–60 years 
(Kuja-Halkola et al., 2012). The number of de novo variants increases with advanced 
paternal age (Buizer-Voskamp et al., 2013; Kong et al., 2012), and de novo variants has been 
shown to be a major cause of neuropsychiatric disorders (Acuna-Hidalgo et al., 2016; Li et 
al., 2016).  
Research in this area has been hampered by a limited ability to holistically phenotype 
violent individuals, to sub-categorize endophenotypes, to collect sufficient cohorts of 
psychiatrically and psychologically well assessed individuals, and to obtain biological 
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materials for genetic studies. Moreover, no single work has yet systematically studied the 
greater spectrum of allelic variation from sequence-level to copy number-variation (CNV), in 
individuals with this phenotype. 
In order to assess the association between impulsive violence and rare chromosomal 
abnormalities and CNV changes, we performed whole–genome genotyping and exome 
sequencing in over 300 extremely impulsively violent males who underwent a standardized 
and detailed clinical characterization and met standard diagnostic criteria for Dissocial 
personality disorder (DPD). It was our intent to enrich the population for individuals who 
might have a genetic rather than environmental basis for their violence. 
Materials and Methods  
Subjects 
The study received approval by the Ethical Committee of the First Psychiatric Clinic, Prague 
and General University Hospital in Prague. Subjects were recruited between June, 2011 and 
March, 2016 from four high security male prisons, two of which have specialized program 
for prisoners with personality disorders. A stringent recruitment protocol was developed. 
First, we selected individuals who, based upon legal proceedings, had been convicted of at 
least two violent attacks (i.e. bodily harm, robbery, murder or attempted murder) and met 
standard diagnostic criteria for dissocial personality disorder. These violent acts were 
impulsive and without pre-meditation. Individuals were not included in the study if the 
violent acts were the result of defensive aggression (i.e response to persistent violent 
bullying or actions performed in order to avoid capture or bodily harm). Other inclusion 
criteria were age > 18 years and the absence of an organic brain disorder. The psychiatrist 
then carried out fifty five prison visits to review prisoner records and determine whether 
the subject also met the standard diagnostic criteria for dissocial personality disorder (DPD). 
The term DPD is not used in the US Diagnostic and Statistical Manual (DSM-5), which uses 
the diagnosis of antisocial personality disorder for a similar cluster of symptoms. Individuals 
with DPD have high levels of impulsivity, high negative emotionality, and low 
conscientiousness and associated behaviours, including irresponsibility and violence. The 
diagnosis of DPD was made only after a detailed discussion of each subject with the first 
author and the psychologists. 
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Using this procedure psychologists screened the records of 6390 individuals and invited 488 
inmates to participate in the study. Thirty-four subjects declined participation, with the 
remaining 454 participants signing a written informed consent once the nature and aims of 
the study were fully explained. The investigators confirmed with the prison staff and related 
to the prisoners that there would be no other benefits to participation and that non-
participation would not be associated with the loss of any benefits or standing. This was 
routinely reinforced and monitored by the study staff. 
A board-certified psychiatrist (JV) assessed all 454 invited participants using the following 
methods: i) the Eysenck IVE Impulsivity Inventory for assessment of personality traits of 
impulsivity, venturesomeness, and empathy, which is a classical trait marker that has been 
validated in the Czech population; ii) the Mini-International Neuropsychiatric Interview - 
M.I.N.I., version 5.0.0 (MINI 5.0) using ICD-10 criteria (Sheehan et al., 1998); iii) the Hare 
Psychopathy Checklist-Revised (PCL-R); iv) the Childhood Experience of Care and Abuse 
questionnaire (CECA.Q; part 5 and 6, concerning physical punishmentbefore age 17 and 
unwanted sexual experiences (Bifulco et al., 2005). The CECA.Q was read to all participants 
during interviews to improve the accuracy of the fixed category responses (Trotta et al., 
2016). Individuals were considered to be impulsive if they scored ≥ 8 on the Eysenck IVE 
Impulsivity scale, which indicates increased impulsivity based on a Czech normative study 
(Senka et al., 1993). The principal reason for using Eysenck's test was that it provides 
quantified data on impulsivity. Individuals who did not complete the entire battery of 
questionnaires or who did not cooperate with the Eysenck test were also included in the 
study if they met the following criteria: (i) after MINI interview with subjects they scored a 
maximal impulsivity score of 2 on the Hare Psychopathy Checklist-Revised, and (ii) after 
extensive review of relevant personal prisoner files and psychiatric assessment by the first 
author of the study, the team of psychologists and psychiatrists reached agreement on the 
impulsive nature of the subject’s repetitive violence. The review procedures were identical 
for all individuals. The nationality and ethnicity of the participants were determined by self-
identification.  
DNA isolation 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
Genomic DNA was extracted from whole blood samples using the Qiagen DNA micro kit 
(QIAgen, Hilden, Germany). The quantity and quality of the isolated DNA was verified using 
the NanoDrop 2000 (Thermo Fisher Scientific, Praha, Czech Republic).  
Microarray genotyping, CNV detection and gene content annotation  
Genotyping was performed using the Illumina Human Omni2.5 SNP array platform (Illumina, 
San Diego, CA) at The Microarray Facility of The Centre of Applied Genomics of The Hospital 
for Sick Children in Toronto as described (Oskoui et al., 2015). Relevant microarray data 
were deposited in the Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/) 
under the accession GSE116022. Quality control procedures and CNV calling were 
performed as previously described (Zarrei et al., 2018b; Oskoui et al., 2015). In brief, three 
CNV calling algorithms were used for both cases and controls: iPattern (Pinto et al., 2011), 
PennCNV (Wang et al., 2007), and QuantiSNP (Colella et al., 2007). We then analyzed 
“stringent” CNVs detected by at least two methods. Detecting large CNVs particularly sex 
chromosomal aneuploidies is challenging (Zarrei et al., 2018b; Zarrei et al., 2018a). In 
addition, these large CNVs are sometimes fragmented. If large CNV´s were found, they were 
merged and their identity confirmed by examining the probe density and “B” allele 
frequencies in the region. The annotation pipeline at The Centre for Applied Genomics was 
used for annotating CNVs.  
Controls and rare CNV detection 
Comparisons were made with external population controls comprised of 10,851 samples 
genotyped on different microarray platforms at TCAG (Zarrei et al., 2018a) and of 2,884 
samples genotyped on Illumina Human Omni2.5 SNP array platform, (platform matched 
controls), from the KORA (Cooperative Health Research in the Region of Augsburg; n=1,775) 
and COGEND (Collaborative Genetic Study of Nicotine Dependence; n=1,109) cohorts. 
Ethnically matched population controls were available from the database of genomics 
variants maintained by the Czech National Center for Medical Genomics; (n=468), 
(http://ncmg.cz/en) and individuals investigated for other non-related clinical phenotype; 
(n= 86) (Stranecky et al., 2016). The control Roma population; (n = 200); consisted of healthy 
individuals who were mostly parents and biologically unrelated family members of families 
who were studied for rare Roma – specific genetic diseases of pediatric onset (Park et al., 
2014; Houstek et al., 2009). These individuals self-identified to be of Roma ancestry as part 
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of an assessment by the Department of Pediatrics and Adolescent Medicine, First Faculty of 
Medicine, Charles University, Prague and Department of Pediatrics and Adolescent 
Medicine, Children's Faculty Hospital, Košice. We defined rare CNVs as having a frequency ≤ 
0.1% among control samples, using a 50% reciprocal overlap strategy as previously 
described (Zarrei et al., 2018b; Gazzellone et al., 2016; Oskoui et al., 2015). We additionally 
restricted the rare variants to: i) those with ≤ 1% frequency among variants in cases, ii) 
those with no identical CNV (using 50% reciprocal overlap strategy) in ethnically matched 
controls, and iii) overlap with no clusters of CNVs in DGV (MacDonald et al., 2014) controls. 
We also removed those with less than 75% overlap with copy number stable regions, 
according to our stringent CNV map of the human genome (Zarrei et al., 2015). CNVs with 
an overlap of > 75% with a structurally unstable region including segmental duplications and 
centromeres of human genome were also excluded. We preferentially investigated CNVs > 
10kb and covered by ≥ 10 consecutive probes. However, if clinically relevant, we also 
considered CNVs < 10kb.  
Ancestry determination 
The ancestry of the cases were determined from genotype data obtained from the 
HumanOmni2.5 microarray and whole exome sequencing as previously described (Oskoui et 
al., 2015; Neroldova et al., 2016).  
Global burden, gene-set and gene network analyses of rare CNVs and prioritization of 
candidate genes 
We performed a global burden of rare CNVs using two metrics: i) the total length of rare 
CNVs per subject, and ii) the number of genes per participant with at least one exon partially 
overlapped by rare CNVs using in house scripts in R (R Development Core Team., 2010); 
(Supplementary material; R-scripts). We stratified CNVs to different bins based on their 
length: 20-100kb, 100-500kb, and those >500kb. Population stratification based on principle 
component analysis of SNP data extracted using PLINK (Purcell et al., 2007) were used as 
covariates. We also performed burden analysis on 34 gene-sets (Merico et al., 2015; 
Engchuan et al., 2015; Gazzellone et al., 2016) representing those with function in human 
brain or human orthologs of mouse genes implicated in nervous system and behavioral 
phenotypes using the general linear model function. Gene set analysis was performed and 
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candidate genes were prioritized through functional annotation tools available in DAVID 
(Database for Annotation, Visualization, and Integrated Discovery) 6.8 (Huang da et al., 
2009), TOPPGENE suit database (Chen et al., 2009), Genopedia (Yu et al., 2010), FUMA 
(Watanabe et al., 2017), and by individual expert evaluation. Gene network analysis was 
performed using the Cytoscape (Shannon et al., 2003). 
Validation of prioritized variants by alternative genotyping methods. 
Existence of selected CNVs was independently assessed either in exome sequence data that 
were available for each of the participants (DNA fragmentation, sequencing library 
preparation, library sequencing and CNV variant detection and annotation were performed 
as described (Neroldova et al., 2016)) and/or validated and genotyped using a Universal 
ProbeLibrary copy number assays using the LightCycler® 480 Instrument (Roche Life Science, 
Prague, Czech Republic). 
Results 
Clinical characterization of subjects 
In total, 313 of 454 (69%) participants were included in the study. (Figure 1). 
The mean age of the participants was 31.5 years (standard deviation; SD=11,6; range 18 - 70 
years). Substance abuse was diagnosed in 268 (86%) participants; (96 alcohol and 172 illegal 
drugs, mostly methamphetamine). Suicidal attempt was reported by 75 (24%) participants. 
The majority of participants (70%) completed an elementary school education, 1% did not 
finish elementary school, 24% graduated from a secondary technical school, and 5% from a 
secondary general school. None of the participants had obtained a university degree. 
Participants had been convicted of a mean of 8.6 criminal offences (SD=5,1; range 2 - 27), 
with 134 participants (43%) reporting a history of criminal conviction in their relatives. Fifty-
two (17%) reported a history of conviction in their fathers, 2 (1%) in their mothers, 25 (8%) 
in a sibling, and 39 (12%) in a sibling and either in a father or mother. Sixteen participants 
(5%) reporting a history of criminal conviction in other relatives. Childhood maltreatment 
was reported by 90 (29%), physical abuse by 80 (26%), and sexual victimization by 18 (6%) of 
participants. Descriptive statistics of PCL and IVE are provided in Table 1.  
Quality control of CNV detection and population stratification of participants  
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From 313 samples, 286 were genotyped and 281 passed stringent quality control for CNV 
detection (Pinto et al., 2011), (Figure 1). The Czech Republic has a population of 10.5 million 
people. The largest ethnic group is comprised of individuals of North-Central European 
ancestry. The second largest ethnic group, with an estimated 245 800 individuals, (2.3% of 
the total population), is of Roma descent. Fifty seven participants self-identified as having 
Roma ancestry at the assessment. Using principal component analysis, we identified 161 
individuals (57 %) as of North-Central European ancestry and 120 individuals (43%) as of 
Roma ancestry, (Figure 2). 
The analysis identified 828 rare CNVs in 264 participants 
Two participants (6998 and 7498) had duplication of chromosome X (eg.47,XXY). At least 
one rare CNV fulfilling the selected criteria was identified in 264 (94%) of 281 participants. 
This represents in total 828 rare CNVs (429 deletions, 399 duplications), (Supplementary 
Material; list “all CNVs”). Distribution of CNV numbers and CNV amounts per participant are 
shown in (Figure 3). From 828 identified CNVs, 533 were genic (eg. impacting exons, 
untranslated regions and introns of a gene), with 251 deletions and 282 duplications. There 
were 420 CNVs impacting protein coding exons, with 159 deletions and 261 duplications. 
Identified CNVs impacted 754 different genes, (Supplementary Material; list “genes”), with 
124 genes impacted more than once (2-25-times), (Figure 3). 
Rare CNV burden, gene set and iteractome analysis and functional annotation of rare 
CNVs identified in impulsively violent males revealed over-representation of disrupted 
genes in several functionally relevant categories  
We stratified CNVs into three categories: 20-100kb, 100-500kb and > 500kb, compared 
global CNV burden against platform-matched male controls (KORA+COGEND) and found no 
significant differences in the size and number of genes impacted by rare CNVs. For gene-set 
enrichment, we tested neuro-sets published before 44; 48; 49, but none met statistical 
significance. We functionally annotated the resulting set of 754 genes impacted by rare 
CNVs  using several gene list annotation programs, including DAVID, TOPPGENE, Genopedia 
and FUMA (see Methods). This analysis identified 97 genes in 87 individuals with established 
links to Online Mendelian Inheritance in Man (OMIM) database, from which 33 genes are 
associated with an autosomal dominant and 5 genes with X-linked transmitted diseases, 
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(Supplementary Material; list “OMIM genes”). The analysis further identified over-
representation of genes impacted by rare CNVs in several functional categories. The most 
over-represented genes in the category of cellular components were found in a gene sets 
related to synapses (GO:0045202), neurons (GO:0097458), mitochondria (GO:0005739) and 
the RNA polymerase III complex (GO:0005666) and ionotrophic glutamate receptor. In the 
category of biological processes, the most over-represented genes were found in a gene 
sets related to synaptic signalling (GO:0099536), regulation of ion transport (GO:0043269), 
cell to cell signalling (GO:0007267), regulation of dendrite development (GO:0050773), 
behavior (GO:0044708) and neurogenesis (GO:0022008). In the categories of gene sets 
associated with human phenotypes through genome-wide association studies, the most 
over-represented genes were in a category related to obesity, intelligence, schizophrenia, 
neuroticism, bipolar disorder, autism and cognitive decline, (Figure 4 A; Supplementary 
Material; list “GWAS hits”). Interactome analysis revealed 12 groups of interacting gene 
clusters that are relevant to impulse control, neurodevelopment and neurodegeneration 
like synaptic protein interactions, ionotrophic glutamate receptor activity, transmission of 
nerve impulses and synaptic vesicle cycle, vesicle–mediated transport, axon guidance and 
cell adhesion, clathrin-mediated endocytosis, Rab-regulation of trafficking, nervous system 
development, DNA replication, RNA polymerase transcription, and 
glycosylphosphatidylinositol-mediated membrane protein anchoring (Figure 4B). Genes 
impacted by CNVs were over-expressed in brain and specific brain regions compare to other 
tissues, with some of the genes demonstrating brain-specific expression patterns (Figure 5).  
Clinical and biological interpretation of genic CNVs defined 31 clinically relevant CNVs and 
142 likely clinically relevant CNVs in 123 impulsively violent males  
To assess the clinical relevance of individual genes impacted by CNVs, we considered their 
clinical associations, biological function, the patterns of gene expression obtained from The 
Genotype-Tissue Expression Project Portal (GTEx) (Mele et al., 2015), genic intolerance to 
deletions and duplications (Ruderfer et al., 2016) and loss of function mutations (Samocha 
et al., 2014), (Supplementary Material; list “constrains and expression”), presence in 
regulatory regions defined by the Encyclopedia of DNA Elements (ENCODE) (Davis et al., 
2018) and the recurrent presence of similar CNVs in individuals with neurobehavioral 
phenotypes reported in the Database of Genomic Variation and Phenotype in Humans 
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(DECIPHER) (Firth et al., 2009). This analysis defined 31 CNVs as clinically relevant and 142 
CNVs as likely clinically relevant (Figure 1). Eighty four individuals had one, 31 individuals 
two, 6 individuals three and 2 individuals four of these rare potentially clinically significant 
CNVs. 
Analysis of recurrent rare CNVs identified 3 males with a microduplication impacting 
MBD5 and suggested association of impulsive violence with an intragenic deletion of CHL1  
Seventeen CNVs classified as clinically relevant or likely clinically relevant were recurrently 
detected in 65 participants (Table 2). Forty-nine individuals had one, twelve individuals two, 
and four individuals three of these CNVs. With the exception of a microduplication 
impacting CALY, all of these recurrent variants were identified in participants of Roma 
origin. To determine if these recurrent CNVs represented rare alterations associated with 
impulsive violence or common variants of Roma population we used qPCR and genotyped 
all these alterations in 90 to 180 Roma control samples. 
In 3 individuals we identified a microduplication impacting MBD5 which encodes Methyl-
CpG-Binding Domain 5 (MBD5) protein. MBD5 mutations result in a syndrome (MIM 
156200) characterized by autosomal dominant (AD) intellectual disability and a broad range 
of neurodevelopmental symptoms including aggressive behaviour (Mullegama SV, 2016).  
In 13 individuals we identified likely clinically relevant deletions in intron 1 of CHL1 which 
encodes Cell Adhesion Molecule L1 Like protein (CHL1). CHL1 is a modulator of the 
serotonergic system; mutations in this gene have been associated with deficits in behavior, 
cognition, and social interactions (Kleene et al., 2015).  
The MBD5 and CHL1 recurrent CNVs did not occur in participants who were directly related. 
The microduplication in MBD5 did not occur in controls, and the CHL1 deletion was 
significantly over-represented compared to controls (FET two tailed, p=0.038) 
The other 15 recurrent functionally relevant CNVs included: i) a microduplication of CPLX1, a 
gene that modulates neurotransmitter release and is a candidate gene for Wolf-Hirschhorn 
syndrome (Bi et al., 2016); ii) a microduplication of NF1, mutations of which are often 
associated with learning disabilities or behavioral problems(Friedman, 2018); iii) an 
intragenic deletion of CNTNAP2, a gene that may affect brain development and acquisition 
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of higher cognitive functions (Poot, 2017); iv) an intragenic deletion FGF12, mutations of 
which are associated with AD early-onset epileptic encephalopathy with cerebellar atrophy 
(MIM 617166) (Siekierska et al., 2016); v) a deletion of brain-specifically expressed 
TMEM235; vi) a microduplication affecting exon2 of ADCY2, a gene that is associated with 
bipolar disorder (van Hulzen et al., 2017); vii) a microduplication of exons 3-6 of CALY that 
encodes calcyon, a protein implicated in various neuropsychiatric disorders including 
schizophrenia, bipolar disorder, attention deficit hyperactivity disorder and drug 
dependence (Luo et al., 2004); viii) a duplication of exons 39-64 of COL11A2, a gene in which 
mutations cause the AD connective tissue disorder Stickler syndrome (MIM 184840), and 
rare de novo CNVs have been also found in Finnish families with autism spectrum disorders 
(Kanduri et al., 2016); ix) a microdeletions in GRID2 encoding the glutamate receptor 
channel delta-2 subunit (GRID2), variations of which has been associated with obsessive-
compulsive disorder (Collaborative, 2017) and AD adult-onset, slowly progressive, cerebellar 
ataxia (Coutelier et al., 2015); x) a deletion of ZNF385D, mutations of which have been 
associated with reading disability (RD) and language impairment (Eicher et al., 2013) and xi) 
a duplications of FAAH encoding Fatty Acid Hydrolase (FAAH) which is known to have a role 
in mediating responses to stress, including stress-associated behavior and variations of 
which has been associated with susceptibility to drug addiction (MIM 602935). The qPCR 
genotyping however showed that all these CNVs were found in similar frequencies in Roma 
controls and thus probably represent population-specific rare polymorphisms whose clinical 
significance is unclear. 
Clinically relevant CNVs identified in 31 individuals 
Thirty-one individuals each had one unique clinically relevant CNV. In addition to 2 
individuals with Klinefelter syndrome (eg. duplication of chromosome X ; 47, XXY) and 3 
individuals with recurrent microduplication impacting MBD5 we identified 26 clinically 
relevant CNVs in 26 other individuals (Table 3).  
There were five CNVs that overlapped in length with CNVs in DECIPHER and ClinGen that 
were identified in multiple individuals with intellectual disability and behavioural 
abnormalities: i) a 600 kb deletion (chr16:21839340-22440319) encompassing 10 genes 
(EEF2K; CDR2; RRN3P3; POLR3E; NPIPB4; C16orf52; MFSD13B; UQCRC2; PDZD9 and VWA3A) 
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affecting EEF2K (which encodes postsynaptic eukaryotic elongation factor 2 kinase and 
balance inhibitory and excitatory synaptic transmission (Heise et al., 2017)) and CDR2 (which 
encodes cerebellar degeneration related protein 2, a major candidate gene (Pizzo et al., 
2017) of the 6p12.2 microdeletion syndrome (OMIM 136570)); ii) a 3.5 Mb duplication 
(chr22:41887922-45396440) that impacts 70 genes some of which are implicated in autism 
(TCF20), steroid-dependent stress and anxiety (TSPO), drug metabolism (CYP2D6), synaptic 
transmission (PACSIN2), neuronal homeostasis (MPPED1), with others specifically expressed 
in brain (LINC00634,SHISA8); iii) a 3Mb duplication (chr11:23211700-26188592), affecting 
LUZ2P, a brain specific protein of unknown function; iv) a 1.7 Mb duplication 
(chr19:27791257-29562474) affecting several non-coding RNAs and genes (LINC01532; 
LOC102724908; LOC100420587; LINC00906; LOC101927151; LOC102724958; and 
LINC00662) whose function is unknown; and v) a 1.3 Mb duplication (chr12:127396986-
128705029) affecting several non-coding RNAs including LINC00507, which is specifically 
and age-dependently expressed in brain, suggesting it may be involved in the brain 
development of higher primates (Mills et al., 2016). 
There were 18 CNVs that affected genes definitively associated with autosomal dominant 
(AD) neurologic phenotypes. These include: i) a duplication impacting the open reading 
frame of KIF26B, which is associated with AD cerebellar ataxia (Nibbeling et al., 2017) 
(OMIM 614026); ii) a contiguous deletion of XPR1 associated with AD basal ganglia 
calcification (Legati et al., 2015) (OMIM 605237) and LHX4 associated with AD combined 
pituitary hormone deficiency type 4 (MIM 262700); iii) a duplication impacting RAB39B and 
CLIC2 that was found in individuals with X-linked intellectual and developmental disability 
(Andersen et al., 2014; El-Hattab et al., 2015) ; iv) a duplication impacting the open reading 
frame of KMT2C that has been associated with AD Kleefstra syndrome 2 (606833) and 
neurodevelopmental phenotypes (Koemans et al., 2017; Faundes et al., 2018); v) a 
duplication impacting the open reading frame of CACNG2 associated with AD mental 
retardation 10 (OMIM 602911) and nonsyndromic intellectual disability (Hamdan et al., 
2011); vi) a duplication impacting the open reading frame of MTOR associated with Smith-
Kingsmore syndrome (OMIM 616638) (Gordo et al., 2017); vii) a duplication impacting the 
open reading frame of CDK13 associated with AD intellectual developmental disorder 
(OMIM 617360) and behavioural problems (van den Akker et al., 2018); viii) a duplication of 
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ZFYVE27 associated with AD spastic paraplegia 33 (MIM 610244), ix) a deletion of the 
regulatory region of ARID1B associated with Coffin-Siris syndrome 1 (MIM 135900) 
presenting with a broad range of neurodevelopmental and behavioural abnormalities 
including hyperactivity and aggressive behavior (Schrier Vergano S, 2018); x) a heterozygous 
multi-exonic deletion of the NRXN1 that has been detected in multiple patients referred for 
intellectual disability, autism spectrum disorder, or seizures, (MIM 614332) (Schaaf et al., 
2012); xi) a microduplication in LRRC7, de novo variants of which were found in patients 
with neurodevelopmental disorders (Popp et al., 2017); xii) a heterozygous deletion 
encompassing exon 3 of DPP associated with AD mental retardation 33 (MIM 616311); xiii) a 
microduplication in the ACMSD that encodes aminocarboxymuconate semialdehyde 
decarboxylase (ACMSD), which prevents the accumulation of the neuronal excitotoxin 
quinolinate that is associated with suicidal behavior (Brundin et al., 2016), and mutations of 
which leads to AD parkinsonism(Marti-Masso et al., 2013); xiv) a multi-exonic deletion of 
CDH7 leading to AD CHARGE syndrome (MIM 214800), which is often associated with 
behavioral abnormalities (Hartshorne et al., 2016) ; xv) an exonic deletion of DLG2, encoding 
a synaptic protein that is linked to developmental disorders and intellectual disability 
(Reggiani et al., 2017), bipolar disorder (Noor et al., 2014) and autism (Egger et al., 2014); 
xvi) a multi-exonic deletion of PTPRD that is highly constrained against deletions in the ExAC 
database, reported in numerous individuals with behavioural abnormalities in the DECIPHER 
database, and variants of which have been associated with a range of neurobehavioral 
phenotypes affecting conformity (Chen et al., 2018), and associated with mood instability 
(Ward et al., 2017), obsessive-compulsive disorder (Collaborative, 2017; Gazzellone et al., 
2016) and attention-deficit hyperactivity disorder (Elia et al., 2010). Deletion and 
haploinsufficiency of PTPRD alter locomotion, sleep behaviors and cocaine-conditioned 
place preference in mice (Drgonova et al., 2015). Another microdeletion of PTPRD affecting 
regulatory region within intron 2 is reported later in this investigation as likely clinically 
relevant; xvii) a multiexonic deletion of GRN leading to AD frontotemporal lobar 
degeneration with ubiquitin-positive inclusions (MIM 607485), which presents in early 
stages with impulsive socially inappropriate behavior (Hsiung G.Y.R, 2007); and xviii) a multi-
exonic deletion of RBFOX1, a candidate gene for aggressive behavior (Fernandez-Castillo et 
al., 2017) that controls neuronal excitation in the mammalian brain (Gehman et al., 2011), 
regulates the expression of synaptic and autism-related genes (Lee et al., 2016), is highly 
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constrained against deletions in the ExAC database, and is reported in numerous individuals 
with autism (Turner et al., 2016; Kanduri et al., 2016), epilepsy (Lal et al., 2015), bipolar 
disorder (Noor et al., 2014) and behavioural abnormalities in the DECIPHER database; 
another microdeletion of RBFOX1 affecting the regulatory region within intron 1 is reported 
later in this investigation as likely clinically relevant. 
Three CNVs were classified as clinically relevant based on relevant phenotypes observed in 
heterozygous knock out mice models. These include: i) a heterozygous 400 kb deletion 
(chr1:145382349-145765424) impacting 21 genes including RBM8A, haploinsufficiency of 
which disrupts embryonic cortical development and results in microcephaly in mice (Mao et 
al., 2015) and intellectual disability in humans (Gamba et al., 2016); ii) a heterozygous 
deletion of the last exon of MDGA2, haploinsufficiency of which leads to an autism-like 
phenotype including stereotypy, aberrant social interactions, and impaired memory in mice 
(Connor et al., 2016) and which is considered a candidate gene for autism in humans (Bucan 
et al., 2009) and iii) a microduplication of a regulatory region and exon 1 of HOMER1, 
encoding a protein that regulates the functional assembly of post-synaptic density proteins 
at glutamatergic synapses, and haploinsufficiency of which in mice leads to increased 
aggression in social interactions (Jaubert et al., 2007). A single individual (288868) with a 
similar microduplication demonstrating aggressive behavior and intellectual disability is 
reported in the DECIPHER database. 
Fifty nine rare, likely clinically relevant CNVs were identified in 49 individuals  
There were 41 individuals who had one, seven individuals with two, and one individual with 
four of these CNVs (Table 4). The most notable CNVs in this group included: i) a deletion of a 
regulatory region in intron 2 of HECW2, mutations of which cause an AD 
neurodevelopmental disorder with hypotonia, seizures, and absent language (MIM 617268) 
(Halvardson et al., 2016) ; ii) a microduplication in CDH13, a gene that impacts GABAergic 
function in hippocampus and cognition (Rivero et al., 2015; Forero et al., 2017), and which 
has been associated with extreme violent behavior in a cohort of Finnish prisoners (Tiihonen 
et al., 2015) and attention-deficit hyperactivity disorder (Neale et al., 2010); and iii) a 
microduplication in neurotrimin (NTM), a gene that has been associated with aggressiveness 
in attention‐deficit hyperactivity disorder (Brevik et al., 2016), late onset Alzheimer disease 
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(Liu et al., 2007), and is linked to developmental delay (Farghaian et al., 2011) in humans 
and whose loss leads to a deficit in emotional learning in Ntm (-/-) mice (Mazitov et al., 2017). 
Other CNVs affect genes that controls synaptic signalling (DLGAP2, DLGAP1, RPH3AL, GRM7, 
PTPRD, NRXN1, P2RX2, MAPK8IP2, JPH3, DOC2B, KCTD16, SDK1, IQSEC3, SNX6, DDC, PALM, 
GLT8D1, WNK2) and re-uptake of GABA (SLC6A12, SLC6A13); and/or are associated with 
neurobehavioral phenotypes like aggressive behavior, autistic disorders, schizophrenia, 
attention deficit hyperactivity disorder, bipolar disorder or sporadic parkinsonism in human 
and/or mouse models (DLGAP2, NRXN1, IL1RAPL2, RBFOX1, MACROD2, SEMA5A, CSMD3, 
DDC, CDH13, MAPK8IP2, NXPH1, GRM7, SLC6A12, SLC6A13, DLGAP1, P2RX2, LAMA1, 
GRIN3A, CMYA5, DDC, IPO11, RPH3AL, TRANK1, SDK1, NINJ1, NRG3, MIDN). 
Some CNVs affected genes that are specifically expressed in the brain, and/or constrained 
against deletions and loss of function mutations, (Figure 5 and Supplementary Material; list 
“constrains and expression”), identifying them as novel candidate genes for impulsive 
behavior. These genes included FBXL16, PHACTR3 (Farghaian et al., 2011), CDH20 
(Collaborative, 2017), FAM155A, DOK6 (Crowder et al., 2004), NKAIN2 (Calboli et al., 2010) , 
STXBP5L (Geerts et al., 2015) or PCDH9 (Marshall et al., 2008; Bruining et al., 2015) UNC13C 
(Pasanen et al., 2018; Chen et al., 2013; Nicod et al., 2016) and DPP10 (Marshall et al., 
2008), C7orf26, FSD1, GLT8D1 (Yang et al., 2018) or GNL3 (Scott et al., 2009). Other 
candidate genes included DNAJC15 and UBE2V2. DNAJC15 is consistently reported to be 
affected in some patients with cognitive impairment reported in the DECIPHER database. 
UBE2V2 has been found overexpressed in brains of aggressive dogs (Vage et al., 2010). 
Discussion 
Impulsively violent behavior is a complex trait that results from multiple genetic and 
environmental factors (Siever, 2008), but the specific genes and their variants (mutations) 
conferring risk are poorly characterized and largely unknown (Asherson and Cormand, 2016; 
Zhang-James and Faraone, 2016).  
With the relative failure of a genome-wide and candidate gene-centered association studies 
(Vassos et al., 2014; Brevik et al., 2016) and the development of novel genotyping and 
sequencing techniques, it has been postulated that genetic components of complex 
phenotypes, such as impulsively violent behavior (Zhang-James and Faraone, 2016), may be 
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deciphered by detailed genetic analysis of extreme cases (Manolio et al., 2009; Maher, 
2008; Barnett et al., 2013; Eichler et al., 2010) and analysis of individual genetic profiles with 
a specific attention to rare variants of potential clinical and biological significance (Cirulli and 
Goldstein, 2010; Lee et al., 2014). 
Following this hypothesis we assessed rare CNVs in 281 individuals from a cohort of 313 
male participants that were classified by strict criteria as having impulsive violence. These 
individuals resided in Czech high security male prisons, two of which have specialized 
program for prisoners with personality disorders. Of 313 offenders, 134 (43%) reported a 
history of criminal conviction in their relatives, suggesting that a genetic component may be 
enriched in this cohort. 
For genotyping we used Illumina HumanOmni2.5 Exome BeadChips that allowed sensitive 
detection of CNVs > 10kb and applied stringent criteria for CNVs definition. We compared 
the frequencies of all 1,525 identified CNVs with KORA, COGEND and internal population-
matched control cohorts and defined in 264 participants a set of 828 rare CNVs. Identified 
rare CNVs impacted 754 genes and 124 genes were impacted more than once (2-25-times).  
Functional annotation and evaluation of genes impacted by CNVs provided important 
insights into the genetics and pathophysiology of impulsive, violent behavior. 
We found that many of the identified CNVs occurred in pathways that are relevant to 
impulsive violence. Impacted genes were over-represented in functional categories and 
biological processes related to synapses, neurons, mitochondrial metabolism, human 
behavior and learning. We also found over-representation of impacted genes in a category 
of gene sets that are associated, through genome-wide association studies, with 
neurobehavioral phenotypes like intelligence, schizophrenia, neurotism, bipolar disorder, 
autism and cognitive decline. Interestingly, the impacted genes are most over-represented 
in a category of obesity-related traits. This finding supports the established link between 
obesity, impulsivity and behavioral problems in children and adults (Matheson and Eichen, 
2018; Michaud et al., 2017). Impacted genes were also enriched for those that are more 
abundantly and specifically expressed in brain and brain specific regions related to impulse 
control. The most prominent enrichment was seen in the anterior cingulate cortex, 
amygdala, basal ganglia and frontal cortex, key structures in the circuitry underlying 
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emotion regulation (Davidson et al., 2000). Most importantly, 97 genes (12 %) of the 
impacted genes are known to cause monogenic diseases reported in the Online Mendelian 
Inheritance in Man (OMIM) database. From these, 33 genes (5%) are associated with an 
autosomal dominant and 5 genes with X-linked transmitted diseases, a finding that is 
compatible with heterozygous deletions or duplications caused by identified CNVs. 
The potential contribution of CNVs to the pathophysiology of the impulsive violence was 
extensive, with 123 (44% of all) participants having 173 CNVs of potential clinical 
significance.  
Important finding was the identification of 17 rare recurrent CNVs of potential significance 
that were present in 65 participants. This finding suggested either that these variants are 
clinically and/or biologically significant or that their recurrence reflect the effect of 
population stratification that is typical for rare variants (Lee et al., 2014). To assess 
population structure, we performed principal component analysis of genotype data from 
whole-exome sequencing and microarray data and found that 161 individuals from the 
studied cohort were of North-Central European ancestry and 120 individuals of Roma origin. 
The majority of the genes recurrently impacted by CNVs were found in individuals of Roma 
origin. The Roma represent the largest ethnic minorities in Czech Republic, its neighbouring 
countries Slovakia and Hungary and across Europe (Martinez-Cruz et al., 2016). Roma 
minorities originate from several founder populations that split, underwent several 
extensive reductions in population size and admixture events due to pogroms and holocaust 
during the last 700 years and thus formed multiple genetically and socially divergent and 
geographically dispersed groups (Morar et al., 2004; Mendizabal et al., 2012). The 
divergence, dispersion, endogamy and genetic admixture with majority population led to a 
high prevalence of deleterious genetic mutations that are rare among other populations and 
even private to specific Roma groups (Mendizabal et al., 2013). The heterogeneity of the 
Roma populations and limited access to DNA samples with sporadic information on health 
status of control individuals from Roma populations prevented rigorous association testing 
of recurrent likely clinically relevant CNVs identified in Roma participants. Nevertheless, rare 
CNVs impacting genes specifically expressed in brain and involved in adult behaviour, 
cognition and learning (NF1, MBD5, CHL1, FGF12, ZNF385D and CNTNAP2), synaptic 
signalling (NF1, GRID2, CPLX1, FGF12), neuronal development and homeostasis processes 
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(NF1, CHL1, GRID2) and drug addiction (FAAH) identified in control Roma populations 
deserve further investigations due to the increased prevalence of anxiety, neuropsychiatric 
diseases, hereditary seizure disorders, and depression in this population (Commission, 
2014).  
In other 31 individuals (11 % of all) we identified 31 rare CNVs that we classified as clinically 
relevant. These include 2 individuals with 47,XXY (Klinefelter syndrome), which is frequently 
associated with specific neurobehavioral features and personality traits (Liberato et al., 
2017). The 47,XXY is one of the most common chromosomal disorders, occurring in 
approximately 1 in 500 to 800 males in the general population (Abramsky and Chapple, 
1997). Our results suggest that this genetic disorder may be over-represented in this cohort. 
The other recurrently identified CNV was a microduplication of exon 4 and its adjacent 
intronic regions in MBD5. MBD5 is a dosage sensitive gene, mutations of which lead to 
autosomal dominant or sporadic developmental delay, motor delay, language impairment, 
autistic-like symptoms and behavioral problems (Hodge et al., 2014; Mullegama SV, 2016; 
Mullegama and Elsea, 2016). This CNV was identified in 3 individuals, all of whom reported a 
history of conviction for criminal activity in their families. This is compatible with an 
autosomal dominant inheritance pattern present in the MBD5-associated 
neurodevelopmental disorder. Comparison of exome-derived genotypes showed that these 
3 individuals are not closely genetically related. However, all three individuals share several 
rare single nucleotide variants around MBD5 locus. This is suggestive that this particular 
CNV has been inherited from their common ancestor and thus may represent another 
relatively frequent deleterious mutation that is specific to Roma population. The other 26 
identified clinically relevant CNVs were private. The 19q11-19q12 duplication, 16p12.1 
microdeletion, microdeletions of DLG2 (Reggiani et al., 2017) and ARID1B (Schrier Vergano 
S, 2018; Jung et al., 2017) and microduplications of MTOR (Gordo et al., 2017), ACMSD 
(Marti-Masso et al., 2013; Thirtamara-Rajamani et al., 2017), MDGA2 (Connor et al., 2016) 
and ZFYVE27 (Mannan et al., 2006) were present in individuals who also reported history of 
criminal conviction in their relatives, further supporting their either firmly established or 
highly suspected clinical relevance. For the remaining 18 clinically relevant CNVs the 
criminal history of siblings was either not mentioned or denied. However, in all these cases 
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the impacted genes are verifiably associated with monogenic autosomal dominant 
neuropsychiatric phenotypes. 
In an additional 49 individuals (17% of all) we identified 59 rare CNVs that we classified as 
likely clinically relevant. Their contribution to the phenotype of impulsively violent behavior 
is not as clear as for the category of clinically relevant variants. However all the impacted 
genes represent highly phenotypically relevant candidates and their contribution require 
further investigations.  
In summary, the primary aim of our study was to describe rare copy number variation in a 
group of participants who were currently in prison, volunteered to participate in this study 
without coercion, and who met strict criteria for impulsive violence. We expected that these 
extreme cases would be enriched for rare CNV variants with large phenotypic effects, and 
that the genes impacted by these CNVs would identify specific biological pathways and 
candidate genes contributing to impulsively violent behaviour. 
In this study we identified 107 unique causative, likely causative, or possibly causative CNVs 
in approximately 44% (123 of 281) of individuals with impulsive violence. There were many 
different genes and pathways involved, without the identification of a predominant gene or 
pathway. This research indicates that extremely impulsively violent individuals likely do not 
share a common genetic condition, but rather each individual has one to several unique 
abnormalities that increase impulsivity that may lead to violence. Thus, an individualized 
approach will be important in the scientific and clinical evaluation of each individual. These 
findings explain the failures of prior analyses such as genome-wide and candidate gene 
based association studies to identify significant findings. In addition, this study shows that 
attempts to classify extremely violent individuals into groups of defined psychiatric 
disorders is likely to be unsuccessful, due to the widely diverse genetic and biologic 
pathophysiology that we identified.  
There were several weaknesses to the study. First, we encountered some difficulties in 
phenotyping violent, anti-social individuals, who often were uncooperative with structured 
tests, even after receiving compensation. The misclassification of individuals may have 
resulted in the inclusion of some individuals who did not have true impulsive violence. We 
believe that this would have likely diluted our findings.  
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Another potential weakness is that some of our genetic findings may have been associated 
with violent behavior in general instead of impulsive violence. In the future, studies of all 
individuals with violent behavior will help to further clarify these findings. Inclusion of all 
violent individuals was beyond the scope of our study.  
In addition, the nature of the study did not allow for collection, phenotyping and genotyping 
of parents and siblings of study participants. Consequence of the absence of clinical and 
genetic information on family members was that we could not determine with certainty 
whether each CNV we identified cosegregated with impulsively violent behavior or arose de 
novo. While de novo CNVs are relatively uncommon, with one study reporting a frequencies 
of de novo CNVs in size from 5-100 kb from 0.1 – 0.01 per generation (Acuna-Hidalgo et al., 
2016), they can occur and be asymptomatic. While the CNVs we identified were rarely 
identified in controls and genome databases, CNVs are often unique. Given the large 
number of CNVs found and the large number of comparisons performed, and given the 
relatively small sample size, there is a significant possibility that some of the CNV findings 
were in fact false positives. Future research will need to be performed to determine the 
clinical significance of each CNV.  
We also encountered a problem with the population stratification of the cohort. 
Heterogeneity of the Roma populations and limited access to DNA samples with sporadic 
information on health status of control individuals from the Roma populations did not 
allowed us to perform a more rigorous assessment of CNVs frequencies and association 
testing of recurrent likely clinically relevant CNVs identified in Roma participants. Another 
weakness of our study was the inclusion of prisoners. While rigid criteria resulted in their 
characterization as having impulsive violence, discrimination and selective prosecution may 
have resulted in a different population than if we were able to include individuals who were 
not in prison. Given the high rates of substance abuse and suicide attempts in the offender 
sample, we also do not know which finding represent specific associations to impulsive 
violence or to substance abuse. 
Despite these weaknesses, we can conclude, that the extreme forms of impulsively violent 
behavior have in many cases a strong genetic component. This genetic component is 
individually specific, and underlies the biologically diverse origin and phenotypic 
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presentation. In many of the investigated cases the genetic findings point to specific 
disorders for which treatments may be present or developed. As the diagnosis of psychiatric 
disorders has been found to improve prisoner care, we believe that the identification of 
these disorders may also be helpful to prisoner care. Individuals with these disorders may 
benefit more from counselling. In addition, training for prison workers in the approach to 
individuals prone to impulsive violence may be helpful to the care of these individuals. We 
strongly believe that these results are preliminary and require further validation.  
It is also extremely important to point out that while the presence of these CNVs in the 
prison population may have contributed to impulsive, violent behavior, the converse is not 
true: the finding of these or similar CNVs in the general population may or may not be 
markers of impulsive, violent behavior. Extensive, population-based studies would be 
required in order to obtain even a limited understanding of the effect of these CNVs in the 
general population. 
Genotyping of extremely violent individuals may result in the diagnosis of neurologic 
diseases, allowing for early detection of disease symptoms and/or placement of these 
incarcerated individuals into yet to be developed specific correctional facilities (Sfera et al., 
2014; Cipriani et al., 2017). The ultimate goal of this work is to identify targets and develop 
individually specific treatments for impulsively violent people. Several of our findings 
provide strong examples of how this approach could be beneficial to affected individuals. 
For example, fatty-acid amide hydrolase (FAAH) inhibitors already used in human (Postnov 
et al., 2018), modulate impulsivity in deprived rats (Marco et al., 2007) and may be 
considered in individuals found here with a duplications of FAAH. Abnormal cognitive and 
social behaviors in Arid1b-heterozygous mice was rescued by treatment with a positive 
allosteric GABAA receptor modulator (Jung et al., 2017). In addition, aberrant behaviors in 
Ninj1 KO mice is ameliorated by fluoxetine (Le et al., 2017).  
 Our findings thus warrant detailed genetic analysis in individuals with extremely impulsively 
violent behavior and provide motivation to perform further studies in a similar cohort of 
extremely impulsively violent women that has been collected by JV and in other 
populations.
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Legends to Figures 
Figure 1 Work flow diagram and summary of results.  
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Figure 2 Principal component analysis (PCA) of participants included in this study. Red 
triangles denote individuals who identified themselves to be of Roma ancestry at the 
assessment. Black triangles denote other participants. This analysis identified 161 
individuals of North-Central European ancestry and 120 individuals as of Roma origin. 
 
  
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
−0.05 0.00 0.05 0.10 0.15
−
0.
1
0.
1
0.
3
PCA 1
PC
A 
2
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
 
Figure 3 Distribution of CNV numbers and CNV amounts in 281 impulsively violent 
individuals. (A) Distribution of CNV numbers, (x-axis), per individual; (B) Distribution of CNV 
numbers (x-axis), and total CNV amounts in bp, (y –axis), per individual. (C) Distribution of 
total CNV amounts in bp across individuals. (D) Density plot of CNV amount per individual. 
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Figure 4 Gene set over-representation and gene network analysis of 754 genes impacted 
by rare CNVs identified in 264 individuals with an ICD 10 Diagnosis of Antisocial 
Personality Disorder. (A) Significant over-representation of impacted genes in the 
categories of cellular components, biological processes and those associated with human 
phenotypes through genome-wide association studies. Hypergeometric tests were 
performed to test if genes of interest are overrepresented in any of the pre-defined gene 
sets; multiple test correction (Benjamini-Hochberg) was performed per category in FUMA 
reported gene sets with adjusted P-value ≤ 0.05. (B) Functional interaction network of genes 
impacted by rare CNVs showing groups of interacting gene clusters relevant to impulse 
control, neurodevelopment and neurodegeneration. Identified clusters (enlarged nodes in 
green ellipses) were annotated by GO, KEGG and Reactome pathway terms. Node colors 
correspond to the relative expression of a given gene in brain normalized to other tissues 
(see the inset). Black gene symbols represent genes impacted by CNVs, red gene symbols 
represents linker genes (not impacted by CNVs). The nodes with twice increased width of 
the border represent genes that were recurrently impacted by particular CNV (see Table 2). 
Edges are displayed as "->" for activating/catalyzing, "-|" for inhibition, "-" for functional 
interactions (FIs) extracted from complexes or inputs, and "---" for predicted FIs. 
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Figure 5 Expression patterns generated in FUMA of 754 genes impacted by CNVs identified 
in 264 individuals with an ICD 10 Diagnosis of Antisocial Personality Disorder. Heat map 
representation of expression patterns of all impacted genes across 53 tissue types based on 
GTEx v7 RNA-seq data is shown on the right. Genes that are specifically expressed in brain 
and/or specific brain regions are shown in detail on the left. Tissues significantly enriched 
for impacted genes, (DEG sets), at Bonferroni corrected P-value ≤ 0.05 are highlighted in red 
on the top. The -log10(P values) in the graph refer to the probability of the hypergeometric 
test.  
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Table 1. Descriptive statistics of 313 males with an ICD 10 Diagnosis of Dissocial Personality Disorder  
 
N Mean Minimum Maximum SD 
Cronbach´s 
alpha 
PCL 313 28.59 4 40 7.01 0.84 
scale 1 interpersonal 313 4.55 0 8 2.49 
 
scale 2 affective 313 5.92 0 8 2.12 
 
scale 3 life style 313 8.10 0 10 1.90 
 
scale 4 antisocial 313 7.34 1 10 2.27 
 
IVE 
     
0.71 
Impulsivity 272 13.13 8 19 2.83 
 
Empathy 272 11.90 3 19 3.50 
 
Venturesomeness 272 10.80 1 16 3.33 
 
PCL - Hare Psychopathy Checklist; IVE - Eysenck IVE Impulsivity scale; Cronbach´s alpha quantifies the internal 
consistencies of corresponding tests; Cronbach´s alpha ≤ 0.7 is considered acceptable and≤ 0.8 good.  
Table 2. Recurrent CNVs of potential significance identified in 65 males with an ICD 10 Diagnosis of Dissocial Personality Disorder and their frequencies in controls  
chr start end size type 
candidate 
gene 
clinical associations 
ethn
icity 
n 
cases 
n 
ctrls 
p-
value 
% all ext. 
Controls 
% all 
Male ext. 
Controls 
% PM 
ext. 
Controls 
% PM 
Male ext. 
Controls 
chr2 148943206 149091754 148549 Dup MBD5 
Mental retardation, autosomal dominant 1; (MIM 
156200) 
R 3/120 0/180 0.063 0.000 0.000 0.000 0.000 
chr3 269208 283807 14600 Del CHL1 
Nonspecific mental retardation, modulator of the 
serotonergic system 
R 13/120 8/181 0.038 0.009 0.020 0.000 0.000 
chr4 759335 784546 25212 Dup CPLX1 
Essential for normal performance of complex 
behaviors 
R 12/120 12/56 ns 0.028 0.040 0.069 0.152 
chr17 29692316 29727873 35558 Dup NF1 Learning disabilities or behavioral problems R 8/120 7/181 ns 0.000 0.000 0.000 0.000 
chr7 146334587 146371099 36513 Del CNTNAP2 
Susceptibility gene implicated in multiple complex 
neurodevelopmental disorders, including autism, 
intellectual disability, and schizophrenia 
R 7/120 10/91 ns 0.009 0.020 0.000 0.000 
chr3 192247712 192266586 18875 Del FGF12 
Epileptic encephalopathy, early infantile 47 autosomal 
dominant; (MIM 617166) 
R 6/120 4/90 ns 0.000 0.000 0.000 0.000 
chr11 89959903 89986667 26765 Dup DISC1FP1 A susceptibility gene for major psychiatric disorders R 5/120 6/181 ns 0.000 0.000 0.000 0.000 
chr17 76219646 76239564 19919 Del TMEM235 Specifically expressed in brain, function unknown R 5/120 3/181 ns 0.000 0.000 0.000 0.000 
chr5 7412827 7472191 59365 Dup ADCY2 Association with ADHD and bipolar disorder R 4/120 2/182 ns 0.055 0.100 0.069 0.152 
chr3 21680527 21732347 51821 Del ZNF385D 
Associated with reading disability and language 
impairment 
R 4/120 4/180 ns 0.000 0.000 0.000 0.000 
chr1 46812747 46961781 149035 Dup FAAH 
Susceptibility to drug addiction; increased levels of 
FAAH activity are involved in the deficits in social 
behavior; (MIM 602935) 
R 4/120 4/180 ns 0.000 0.000 0.000 0.000 
chr6 33114647 33139662 25016 Dup COL11A2 
Otospondylomegaepiphyseal dysplasia, autosomal 
dominant; Stickler syndrome type III; (MIM 184840) 
R 3/120 1/159 ns 0.018 0.040 0.035 0.076 
chr10 135129012 135141572 12561 Dup CALY 
Calcyon; role in neuronal development, synaptic 
function, and neurodegeneration 
C 2/161 nd ns 0.009 0.020 0.035 0.076 
chr6 5242102 5393392 151291 Del FARS2;LYRM4 Associated with cognitive deficit in schizophrenia R 2/120 3/90 ns 0.018 0.020 0.035 0.000 
chr4 93233136 93302533 69398 Del GRID2 
Associated with obsessive-compulsive disorder; GRID2 
mutations span from congenital to mild adult-onset 
cerebellar ataxia. 
R 2/120 2/90 ns 0.000 0.000 0.000 0.000 
chr10 42680389 43374443 694055 Dup 
LINC00839, 
ZNF33B 
Expressed in brain, molecular function is unknown R 2/120 nd na 0.028 0.040 0.035 0.076 
chr16 16363239 16682080 318842 Dup 
NPIPA8, 
NPIPA7 
Expressed in brain,  
16p13.11 recurrent microduplication neurocognitive 
disorder susceptibility locus 
R 2/120 nd na 0.018 0 0 0 
R, C- individuals of Roma or Caucasians origin; n cases and controls – number of individuals with particular variant/number of individuals from the corresponding population; p-value - Fisher exact test statistic value 
for differences in CNV frequencies between cases and controls; frequencies of CNVs in all external controls (n = 10.851), external control males, and platform matched (PM) external controls (n = 2884) and male 
external controls are provided. Ns – not significant; nd – not done; na – not available 
Table 3. Clinically relevant copy number variants identified in 31 males with an ICD 10 Diagnosis of Dissocial Personality Disorder 
SID/ 
heredity 
Et chr start end size type candidate genes clinical association 
6998/0 C chrX 1 155270560 155270560 Dup  Klinefelter syndrome 
7498/1 R chrX 1 155270560 155270560 Dup  Klinefelter syndrome 
7542/0 C chr22 41887922 45396440 3508519 Dup TCF20, TSPO, CYP2D6, 70 genes; overlapping CNVs found in multiple individuals with ID 
499G/0 C chr11 23211700 26188592 2976893 Dup LUZP2 Brain specific protein of unknown function; overlapping CNVs found in multiple individuals with ID 
1221G/1 C chr19 27791257 29562474 1771218 Dup LINC00662 Brain expressed ncRNAs; overlapping CNVs found in multiple individuals with ID 
3492G C chr12 127396986 128705029 1308044 Dup LINC00507 Age-dependently expressed in brain; overlapping CNVs found in multiple individuals with ID 
7503/0 C chr1 245804664 246651577 846914 Dup KIF26B;SMYD3 AD cerebellar ataxia 53; (OMIM 614026); overlapping CNVs found in multiple individuals with ID 
7567/1 R chr16 21839340 22440319 600980 Del EEF2K; CDR2 10 genes, recurrent 16p12.1 microdeletion (OMIM 136570); neurodevelopmental susceptibility locus 
2507G/0 R chr1 180089858 180656059 566202 Del XPR1, QSOX1 7 genes, XPR1 is associated AD basal ganglia calcification, idiopathic, 6; (OMIM 605237) 
3553G C chr16 6322276 6770650 448375 Del RBFOX1 A candidate for aggressive behavior; CNVs enriched in children with developmental disorders 
3486G C chrX 154119023 154563670 444648 Dup RAB39B 8 genes, Mental retardation, X-linked; RAB39B is involved also in Parkinson disease and autism 
1220G/1 C chr11 84034817 84469196 434380 Del DLG2 Synaptic protein linked to developmental disorders, ID, bipolar disorder and autism 
7707/0 C chr1 145382349 145765424 383076 Del RBM8A, GNRHR2 21 genes, Mice heterozygous for Rbm8a deletion exhibit aberrant neurogenesis and microcephaly 
1101G/0 R chr18 63504872 63859664 354793 Del CDH7 AD CHARGE syndrome; (MIM 214800), synaptic expression 
7575/0 R chr7 151748737 152050571 301835 Dup KMT2C AD Kleefstra syndrome 2; (MIM 606833) 
859G/0 C chr9 10225428 10512307 286880 Del PTPRD 
Associated with mood instability, major depressive disorder, anxiety disorder and schizophrenia; 
behavioral abnormalities in Ptprd–/– mice 
972G/0 C chr22 36695173 36966418 271246 Dup CACNG2 5 genes, CACNG2 is associated with AD mental retardation 10 (OMIM 602911) and intellectual disability 
7453/1 R chr1 11305316 11530369 225054 Dup MTOR Smith-Kingsmore syndrome; (OMIM 616638) 
7576/1 C chr14 47150378 47315071 164694 Del MDGA2 Haploinsufficiency alters cortical dynamics and cognitive function 
2325G/0 C chr7 39919353 40073434 154082 Dup CDK13 Associated with AD intellectual developmental disorder; (OMIM 617360) and behavioural problems 
1602G/0 C chr2 51118081 51266798 148718 Del NRXN1 Heterozygous intragenic deletions found in patients with ID and autism; (MIM 614332) 
7672/1 R chr2 148943206 149091754 148549 Dup MBD5 Mental retardation, autosomal dominant 1; (MIM 156200) 
3482G/1 R chr2 148943657 149091754 148098 Dup MBD5 Mental retardation, autosomal dominant 1; (MIM 156200) 
7545/1 R chr2 148943657 149050617 106961 Dup MBD5 Mental retardation, autosomal dominant 1; (MIM 156200) 
7549/1 R chr10 99490436 99573168 82733 Dup ZFYVE27 Associated with AD spastic paraplegia 33; (MIM 610244) 
7336/0 C chr5 78767898 78819404 51507 Dup HOMER1 Heterozygous KO mice showed increased aggression in social interactions with conspecifics 
1103G/1 R chr6 157334519 157372427 37909 Del ARID1B Regulatory region of the gene that is associated with AD Coffin-Siris syndrome 1 (MIM 135900) 
7588/1 C chr2 135572382 135600749 28368 Dup ACMSD Associated with AD Parkinson's disease 
3476G R chr1 70377391 70399318 21928 Dup LRRC7 De novo variants found in patients with neurodevelopmental disorders 
7590/0 C chr7 154161235 154172154 10920 Del DPP6 AD mental retardation 33; (MIM 616311) 
7551/0 C chr17 42425313 42432774 7462 Del GRN AD frontotemporal lobar degeneration with ubiquitin-positive inclusions; (MIM 607485) 
SID- id number/heredity (father and/or sibs) – 1 yes, 0 no; Et- ethnicity - R, C- individuals of Roma or Caucasians origin; AD – autosomal dominant; ID – intellectual disability 
 
Table 4. Likely clinically relevant copy number variants identified in 49 males with an ICD 10 Diagnosis of Dissocial Personality Disorder 
SID Et chr start end type size candidate gene clinical association 
7542/0 C chr7 6647725 6697851 Del 50127 C7orf26 Overexpressed in brain, constrained against deletions and loss-of-function mutations 
  chr16 736998 766690 Del 29693 WDR24, METRN 
WDR24 is a component of the GATOR2 complex regulating mTORC1 pathway. METRN regulates glial cell 
differentiation and promotes the formation of axonal networks during neurogenesis. 
  chr19 1226555 1251781 Del 25227 MIDN, C19orf26 
MIDN is a regulator of parkin expression, deletions associated with Parkinson's Disease. C19orf26 is 
specifically expressed in brain, its molecular function is unknown 
  chr22 51035885 51048721 Del 12837 MAPK8IP2 
IB2 is expressed in the brain and is highly enriched within postsynaptic densities; cognitive deficits in IB2 
(-/-) mice due to synaptic transmission deficits 
3550G C chr3 163800507 164042296 Dup 241790 MIR1263 Recurrent duplications in ID 
  chr18 7080135 7171561 Del 91427 LAMA1 De novo and rare inherited CNVs in the hemiplegic form of cerebral palsy. 
1121G/1 C chr5 9013766 9083548 Del 69783 SEMA5A 
Associated with autism spectrum disorders; de novo microdeletion of SEMA5A found in a boy with 
autism and ID 
  chr10 84139399 84186263 Del 46865 NRG3 Specifically expressed in brain; regulates impulsive action. 
502G/0 C chr7 8394248 8540295 Dup 146048 NXPH1 
Involved in synaptic transmission and differentiation of synaptic contacts. Associated with ADHD and 
autism. 
  chr16 87693428 87706185 Del 12758 JPH3 Amplification of repeats within JPH3 leads Huntington disease-like 2 
525G/1 C chr18 66982638 67072149 Dup 89512 DOK6 Promotes Ret-mediated neurite outgrowth 
  chr19 4320022 4372780 Dup 52759 FSD1 Specifically expressed in brain, molecular function unknown; 
7590/0 C chr6 124264221 124352163 Del 87943 NKAIN2 Specifically expressed in brain; associated with extraversion and neurotism 
  chr19 20718734 20925934 Dup 207201 
ZNF626, 
ZNF737 
Overlapping amplifications of ZNF626 were found in multiple individuals with ID and behavioral 
abnormalities. ZNF737 has been associated with reading disability and ADHD 
7539/1 C chr5 61885501 61904389 Dup 18889 IPO11 Rare variants are associated with ADHD in Caucasians. 
  chr11 100704714 101436561 Dup 731848 TMEM133 Constrained against duplication CNVs, biological function unknown 
7468/1 C chr7 50530869 50541135 Del 10267 DDC 
DOPA decarboxylase, association with Nicotine Dependence; functional common polymorphisms in the 
DDC gene might contribute to neural processes relevant to neuropsychiatric illness and treatment. 
  chr20 58326432 58342420 Del 15989 PHACTR3 A regulator of neurite outgrowth and neuroplasticity in the brain. 
2698G R chr9 10547083 10595208 Del 48126 PTPRD 
Associated with mood instability, major depressive disorder, anxiety disorder and schizophrenia; 
behavioral abnormalities in Ptprd–/– mice 
2700G/1 R chr15 54888538 54926493 Del 37956 UNC13C Constrained against mutations, overexpressed in brain; rare mutations in dementia in a Finnish cohort. 
3473G R chr20 14481403 14604808 Del 123406 MACROD2 
Rare CNVs identified in individuals with ADHD; Overlapping CNVs found in multiple individuals with ID 
and autism 
3487G R chr2 116342244 116362694 Del 20451 DPP10 Linked to ADHD; constrained against  mutations, overexpressed in brain 
3491G C chr16 6874144 6891002 Del 16859 RBFOX1 A candidate for aggressive behavior; CNVs enriched in children with developmental disorders 
3496G C chr8 896237 929794 Del 33558 DLGAP2 Rare CNVs in autism spectrum disorders; Dlgap2 -/- mice demonstrate exacerbated aggressive behaviors 
3555G C chr13 108294075 108358850 Del 64776 FAM155A Specifically expressed in brain, constrained against duplications and loss of function mutations 
1063G/1 R chr18 3821489 3848159 Dup 26671 DLGAP1 
Association with ADHD; Dlgap1 (-/-) mice exhibit alterations of the postsynaptic density and selective 
reductions in sociability. 
1070G/1 C chrX 104559318 105083783 Dup 524466 IL1RAPL2 
Specifically expressed in brain. Overlapping CNVs found in multiple individuals with ID and autism. 
Microdeletions in females with severe ID, hypotonia and behavioral abnormalities. 
1098G/0 C chr3 6933866 6983750 Dup 49885 GRM7 
Glutamate receptor; associated with ADHD; rare CNV variants identified in patients with psychiatric 
disorders 
1119G/0 C chr12 133137528 133253195 Dup 115668 POLE,P2RX2 Overlapping CNVs found in multiple individuals with ID and autism 
1120G/0 C chr11 130821810 131476469 Dup 654660 NTM Overlapping CNVs found in multiple individuals with ID and autism, associated with aggressiveness  
1213G/0 R chr7 4018597 4476949 Dup 458353 SDK1 Association with ADHD; CNV variants in the brain of schizophrenia patients 
1214G/1 C chr6 57220778 57632044 Dup 411267 PRIM2 Overlapping CNVs found in multiple individuals with ID 
1220G/0 C chr8 140805932 140869942 Del 64011 TRAPPC9 De novo mutation in schizophrenia, Mental retardation, autosomal recessive 13; (MIM 613192) 
1594G/1 C chr16 82179289 83668937 Dup 1489649 CDH13 Genetic background of extreme violent behavior; associated with ADHD 
1616G/1 C chr2 197250296 197264236 Del 13941 HECW2 Neurodevelopmental disorder with hypotonia, seizures, and absent language; (MIM 617268) 
2562G/1 C chr11 89232161 89822105 Dup 589945 NOX4 Overlapping CNVs found in multiple individuals with ID and behavioral abnormalities 
379G/0 C chr8 1117573 1144799 Del 27227 DLGAP2 Rare CNVs in autism spectrum disorders; Dlgap2 -/- mice demonstrate exacerbated aggressive behaviors 
477G/0 C chr13 67380739 67397532 Del 16794 PCDH9 
Specifically expressed in brain; CNVs in autism; PCDH (+/-) mice showed long-term social recognition 
impairment 
478G/0 C chr19 746206 770528 Dup 24323 PALM 
Implicated in plasma membrane dynamics in neurons, phosphoprotein associated with brain synaptic 
plasma membranes. It is also abundant in several endocrine tissues 
483G/0 C chr13 43452859 43792305 Dup 339447 
ENOX1,DNAJC15, 
EPSTI1 
Overlapping CNVs found in multiple individuals with ID and autism 
486G/0 C chr7 149509048 149522447 Dup 13400 SSPO Associated with structural connectivity and information processing in the brain. 
530G/0 C chr9 95892712 96015165 Dup 122454 WNK2;NINJ1 
WNK2 regulates cell volume and/or GABAergic signalling; NINJ1 plays a role in nerve regeneration; Ninj1 
(-/-) mice are reminiscent of mouse models of neuropsychiatric disorders. 
546G/0 C chr3 121081880 121155725 Dup 73846 STXBP5L Plays a role in vesicular trafficking and neurotransmitter release 
7019 C chr12 133137528 133272761 Dup 135234 POLE, P2RX2 Overlapping CNVs found in multiple individuals with ID and autism 
7412 C chr17 2220 103469 Del 101250 DOC2B, RPH3AL 
DOC2B act as calcium sensor to trigger spontaneous release from synaptic vesicles. Overlapping deletions 
of RPH3AL were found in multiple individuals with ID 
7467/0 C chr9 103860319 104371736 Del 511418 
GRIN3A, ZNF189, 
PPP3R2 
PLPPR1 and ZNF189 are specifically expressed in brain; GRIN3 is involved in the development of synaptic 
elements 
7469/0 R chr1 36626006 36645615 Del 19610 MAP7D1 Facilitate axon elongation of cortical neurons 
7501/0 C chr14 35021090 35061728 Dup 40639 SNX6 
Ablation of SNX6 leads to defects in synaptic function of CA1 pyramidal neurons and spatial memory. 
Interacts with HOMER1 
7536/0 R chr5 79069469 79120797 Del 51329 CMYA5 Associated with schizophrenia in multiple populations 
7577/1 C chr18 3981701 3998627 Dup 16927 DLGAP1 
Association with ADHD; Dlgap1 (-/-) mice exhibit alterations of the postsynaptic density and selective 
reductions in sociability. 
7578/0 R chr8 48964607 48999011 Del 34405 UBE2V2 Differential expression of the UBE2V2 in brains of aggressive and non-aggressive dogs. 
7617/0 C chr12 260682 592524 Dup 331843 
SLC6A13, 
SLC6A12, 
IQSEC3 
SLC6A13 encodes major transporter for gamma-aminobutyric acid; SLC6A12 encodes a transporter of 
betaine; IQSEC3 is expressed specifically in the adult brain and rare CNVs were identified in patients with 
anxiety disorders 
7618/0 C chr2 50952084 50970602 Del 18519 NRXN1 
Microdeletions have been associated with neurodevelopmental disorders, including autism, 
schizophrenia, intellectual disability, speech and language delay, epilepsy and hypotonia. 
7636/1 R chr5 143416602 143645872 Dup 229271 KCTD16 
Determines the kinetics of the GABAB receptor response; may contribute to hyper-reactivity to aversive 
stimuli in neuropsychiatric disorder 
7674/1 C chr3 36948417 37017024 Del 68608 TRANK1 Associated with bipolar disorder. 
7700/ R chr5 61698663 61977629 Dup 278967 IPO11 Rare variants are associated with ADHD in Caucasians. 
7703/1 R chr3 52596914 52735364 Del 138451 GNL3, GLT8D1 Associated with bipolar disorder in individuals of European ancestry. 
863G/0 C chr8 113219539 113281792 Dup 62254 CSMD3 Candidate gene for ID and autism 
972G/0 C chr2 50495613 50513774 Del 18162 NRXN1 
Microdeletions have been associated with neurodevelopmental disorders, including autism, 
schizophrenia, intellectual disability, speech and language delay, epilepsy and hypotonia. 
SID- id number/heredity (parents and/or sibs) – 1 yes, 0 no; Et- ethnicity - R, C- individuals of Roma or Caucasians origin; ADHD – attention deficit hyperactivity disorder; 
ID– intellectual disability 
